Cyclic nucleotide metabolism in compensatory renal hypertrophy and neonatal kidney growth

Proc Natl Acad Sci U S A. 1976 Feb;73(2):524-8. doi: 10.1073/pnas.73.2.524.

Abstract

Cyclic nucleotide metabolism was investigated in growing kidneys of rats during compensatory hypertrophy and during neonatal development. After unilateral nephrectomy a mild and short-lasting decrease in cyclic 3':5" adenosine monophosphate (cAMP) was observed in the hypertrophying kidney. In contrast, cyclic 3':5' guanosine monophosphate (cGMP) showed a sharp decline to 20% of control at 15 min and a rapid rise to 200-300% above base-line at 1-72 hr. The alterations in renal tissue levels of cGMP were associated with parallel changes in the soluble, 100,000 X g supernatant guanylate cyclase activity [GTP pyrophosphate-lyase (cyclizing): EC 4.6.1.2]. No change was observed in total cGMP phosphodiesterase (3':5'-cyclic-nucleotide 5'-nucleotidohydrolase; EC 3.1.4.17). In the rapidly growing kidney of newborn rats cAMP levels were 983 +/- 65 and 833 +/- 42 pmol/g of kidney at 4 and 7 days after birth, and increased to adult levels (1518 +/- 57 pmol/g) at 21 days whereas cGMP levels were 59.8 +/- 6.8 and 92.5 +/- 13.9 pmol/g at 4 and 7 days and decreased to adult levels (36 +/- 1.5) at 21 days. The results indicate that compensatory renal hypertrophy and neonatal kidney growth are associated with changes in cAMP and cGMP metabolism.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3',5'-Cyclic-AMP Phosphodiesterases / metabolism
  • Age Factors
  • Animals
  • Guanylate Cyclase / metabolism
  • Hypertrophy / metabolism
  • Kidney / enzymology
  • Kidney / growth & development*
  • Kidney / metabolism
  • Male
  • Nucleotides, Cyclic / metabolism*
  • Rats

Substances

  • Nucleotides, Cyclic
  • 3',5'-Cyclic-AMP Phosphodiesterases
  • Guanylate Cyclase